Lugui Qiu

Also affiliated with Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, National Clinical Research, Magbro Healthcare (India), Tianjin Hospital, Institute of Hematology & Blood Diseases Hospital, Southeast University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma”.

YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma

Blood(2020)10.1182/blood.2019004147

N/A

0.500DataRank · unranked

27 citations

Mariateresa Fulciniti, Mehmet Samur, Matthew Ho, Shuhui Deng, Lanting Liu +20 more

Ibrutinib alternating with three cycles of interval fludarabine, cyclophosphamide, and rituximab (FCR) in adults with untreated chronic lymphocytic leukaemia as time-limited regimen: a single-arm, multicentre phase 2 trial in China

eClinicalMedicine(2025)10.1016/j.eclinm.2025.103688

N/A

0DataRank · unranked

0 citations

Yuting Yan, Hui Wang, Ying Sun, Xiantao Liu, Rui Lyu +14 more